Related Experiment Video
Updated: Jan 24, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants
Katie J Ryan1,2,3,4, Charles C White1,2,4, Kruti Patel1,2,3,4
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Microglia are emerging as a key cell type in neurodegenerative diseases, yet human microglia are challenging to study in vitro. We developed an in vitro cell model system composed of human monocyte-derived microglia-like (MDMi) cells that recapitulated key aspects of microglia phenotype and function. We then used this model system to perform an expression quantitative trait locus (eQTL) study examining 94 genes from loci associated with Alzheimer's disease, Parkinson's disease, and multiple sclerosis. We found six loci (CD33, PILRB, NUP160, LRRK2, RGS1, and METTL21B) in which the risk haplotype drives the association with both disease susceptibility and altered expression of a nearby gene (cis-eQTL). In the PILRB and LRRK2 loci, the cis-eQTL was found in the MDMi cells but not in human peripheral blood monocytes, suggesting that differentiation of monocytes into microglia-like cells led to the acquisition of a cellular state that could reveal the functional consequences of certain genetic variants. We further validated the effect of risk haplotypes at the protein level for PILRB and CD33, and we confirmed that the CD33 risk haplotype altered phagocytosis by the MDMi cells. We propose that increased LRRK2 gene expression by MDMi cells could be a functional outcome of rs76904798, a single-nucleotide polymorphism in the LRKK2 locus that is associated with Parkinson's disease.
Insights
Researchers developed human microglia-like cells to study neurodegenerative diseases. Genetic analysis revealed specific gene variants influencing disease risk and expression, particularly in Parkinson's disease.
Area of Science:
- Neuroimmunology
- Genetics
- Neurodegenerative Diseases
Background:
- Microglia play a crucial role in neurodegenerative diseases.
- Studying human microglia in vitro presents significant challenges.
- Existing models do not fully capture microglial complexity.
Purpose of the Study:
- To develop a robust in vitro model of human microglia.
- To investigate the functional impact of genetic variants associated with neurodegenerative diseases.
- To identify cis-eQTLs in microglia-like cells relevant to Alzheimer's, Parkinson's, and multiple sclerosis.
Main Methods:
- Development of human monocyte-derived microglia-like (MDMi) cells.
- Expression quantitative trait locus (eQTL) analysis of 94 disease-associated genes.
- Validation of genetic variant effects at the protein level and functional assays (phagocytosis).
Main Results:
- Six loci (CD33, PILRB, NUP160, LRRK2, RGS1, METTL21B) showed cis-eQTLs in MDMi cells.
- Specific cis-eQTLs were identified in MDMi cells but not in monocytes (PILRB, LRRK2).
- Risk haplotypes for PILRB and CD33 were validated at the protein level; CD33 risk haplotype impaired phagocytosis.
Conclusions:
- MDMi cells provide a valuable model for studying human microglia in vitro.
- Genetic variants associated with neurodegenerative diseases can alter gene expression and function in microglia-like cells.
- The study implicates altered LRRK2 expression in Parkinson's disease pathogenesis due to a specific SNP.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Histone Variants at the Centromere
Gene Flow
Gene Therapy
Organization of Genes
Biological Effects of Radiation

